GATA3 and myeloid sarcoma: In the healthy control group and patients with MS, the differences in the expression of T-bet/GATA-3 ratio between MOG-stimulated and non-stimulated PBMC were not statistically significant, although, this ratio was higher in MOG-stimulated PBMCs (Table 3).